CLINICAL CASE

A case report of DOPA-responsive dystonia in a young woman

Belykh NA2, Akhkyamova MA2, Gusev VV1,2,3, Lvova OA2,3
About authors

1 Central Clinical Hospital № 23, Yekaterinburg, Russia

2 Ural State Medical University, Yekaterinburg, Russia

3 Yeltsin Ural Federal University, Yekaterinburg, Russia

Correspondence should be addressed: Nikita А. Belykh
Repina, 3, Yekaterinburg, 620014; moc.liamg@hkilebatikin

About paper

Compliance with ethical standards: the study was approved by the Ethics Committee of Ural State Medical University (Protocol № 1451/19 dated September 20, 2019). The patient gave informed consent to participate in the study.

Author contribution: Belykh NA analyzed the literature, made the differential diagnosis, participated in establishing the definitive diagnoses followed the patient up for 3 years. Akhkyamova MA examined the patient, collected her medical history, participated in establishing the diagnosis, followed the patient up for 3 years, wrote the manuscript. Gusev VV followed the patient up; ordered diagnostic tests, prescribed treatment and monitored its course; provided the patient’s medical history; helped with the application to the Ethics Committee. Lvova OA advised the patient on the genetic test and interpreted its results.

Received: 2020-05-14 Accepted: 2020-05-28 Published online: 2020-06-05
|
  1. Segawa M, Ohmi K, Itoh S, Aoyama M, Hayakawa H. Childhood basal ganglia disease with remarkable response to L-Dopa, hereditary basal ganglia disease with marked diurnal fluctuation. Shinryo. 1971; 24: 667–72.
  2. Roubertie A, Mariani LL, Fernandez-Alvarez E, Doummar D, Roze E. Treatment for dystonia in childhood. Eur J Neurol. 2012; 19 (10): 1292–9. DOI: 10.1111/j.1468-1331.2011.03649.x.
  3. Lin J, Lumsden DE, Gimeno H, et al. The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study. J Neurol Neurosurg Psychiat. 2014; 85: 1239–44.
  4. Gouider-Khouja N, Kraoua I, Benrhouma H, Fraj N, Rouissi A. Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol. 2010; 14 (4): 304–7. DOI: 10.1016/j.ejpn.2009.11.005.
  5. Wassenberg T, Schouten MI, Helmich RC, Willemsen MAAP, Kamsteeg EJ, van de Warrenburg BPC. Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset [published online ahead of print, 2020 Apr 1]. Parkinsonism Relat Disord. 2020; 74: 12–15. DOI: 10.1016/j.parkreldis.2020.03.019.
  6. Wijemanne S, Jankovic J. Dopa-responsive dystonia — clinical and genetic heterogeneity. Nat Rev Neurol. 2015 Jul; 11 (7): 414– 24. DOI: 10.1038/nrneurol.2015.86.
  7. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Advances in Neurology. 1988; 50: 377–84.
  8. Van Hove JL, Steyaert J, Matthijs G, Legius E, Theys P, Wevers R, et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiat. 2006; 77: 18–23. Available from: https://DOI.org/10.1136/jnnp.2004.051664.
  9. Camargo CHF, Camargos ST, Cardoso FEC, Teive HAG. The genetics of the dystonias — a review based on the new classification of the dystonias. Arquivos de neuropsiquiatria. 2015; 73 (4): 350–8.
  10. Lohmann K, Klein C. Update on the genetics of dystonia. Current neurology andneuroscience reports. 2017; 17 (3): 26.
  11. Zirn B, Steinberger D, Troidl C, Brockmann K, von der Hagen M, Feiner C, et al. Frequency of GCH1 deletions in Dopa‐responsive dystonia. J Neurol Neurosurg Psychiat. 2008; 79: 183–6. Available from: https://DOI.org/10.1136/jnnp.2007.128413.
  12. Lee W-W, Jeon BS. Clinical spectrum of dopa-responsive dystonia and related disorders. Curr Neurol Neurosci Rep. 2014; 14 (7): 461. Available from: https://DOI.org/10.1007/s11910-014-0461-9.
  13. Van Egmond ME, Kuiper A, Eggink H, Sinke RJ, Brouwer OF, VerschuurenBemelmans CC, et al. Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm. J Neurol Neurosurg Psychiat. 2015; 86 (7): 774–81. Available from: https://DOI.org/10.1136/jnnp-2014-309106.